Since TP2 micronutrients show an effect on cancer treatment, which has been confirmed by the testimonies of many people, it was decided to conduct laboratory tests to determine the effect of the product on cancer cells.
Research Unit
Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences Laboratory of Experimental Anticancer Therapy
Method of conducting the study
The study was performed in vitro (under laboratory conditions) on five human cancer cell lines: lung cancer, prostate cancer, breast cancer, ovarian cancer, colorectal cancer.
The TP2 preparation was applied directly to tumor cells at various concentrations (dilutions). The number of cells after treatment with the test formulations was compared to the number of control cells (treated with nothing) and was determined as % of live cells compared to control cells treated as 100%.
The TP2 formulation at the highest dilution used, 1:400, inhibited prostate cancer cells by about 78 % (under laboratory conditions), meaning live prostate cancer cells were left with only about 22 % compared to control cells.
The TP2 formulation at the highest dilution used, 1:400, inhibited colon cancer cells by about 97 % (under laboratory conditions), meaning that live colon cancer cells were left with only about 3 % compared to control cells.
The TP2 formulation of lung cancer and breast cancer tumor cells inhibited by about 96 %, meaning that live lung cancer and breast cancer tumor cells were left with only about 4%.
The TP2 formulation at the highest dilution used, 1:400, inhibited lung cancer tumor cells by about 96 % (under laboratory conditions), meaning live lung cancer tumor cells were left with only about 4 % compared to control cells.
The TP2 formulation at the highest dilution used, 1:400, inhibited breast cancer tumor cells by about 96 % (under laboratory conditions), meaning live breast cancer tumor cells were left with only about 4 % compared to control cells.
Dr. Tadeusz Podbielski began his work and research on TP preparations in 1945. Below are the opinions of other experts and institutions after the research and verification of TP preparations.
Academy of Medicine in Poznan referring to the Department's determinations of Co, Mg, Zn ions in the TP1 preparation and Co, Mg, Zn, Cu, Fe ions in the TP2 preparation, developed by Dr. Podbielski, I state that the professional literature does not indicate that this composition and the dosage method can pose a threat to human health.
Prof. Dr. Jan Pawlaczyk, Academy of Medicine in Poznań, April 28, 2003.
The Institute of Food and Nutrition in response to the letter of opinion on micronutrients TP1 and TP2 products according to Dr. Tadeusz Podbielski: the institute has no objections to the composition of the aforementioned products and the proposed dosage.
Deputy Director for Food Safety Dr. n. med. Lucjan Szponar, Prof. Dr. Aleksander Szczygiel Institute of Food and Nutrition, Warsaw, December 5, 2003.
The Chief Sanitary Inspectorate kindly informs: the above-mentioned products received a positive opinion from the Institute of Food and Nutrition on December 5, 2003 and can be marketed in Poland.
Director Maria Stachowiak, Chief Sanitary Inspectorate, February 17, 2004.
You pay only for the cost of shipping - the product itself is free.
Order now - 0 zł Information leafletImportant: Supporting the body with micronutrients does not replace medical treatment, but is a valuable complement to it. Any supplementation should be preceded by blood tests to determine any deficiencies or excesses, and should be consulted with the attending physician.
We continue Dr. Tadeusz Podbielski's mission - TP2 micronutrients available to anyone who needs them.
